These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Alpha-synuclein in Parkinson's disease: light from two new angles. Golbe LI; Mouradian MM Ann Neurol; 2004 Feb; 55(2):153-6. PubMed ID: 14755715 [No Abstract] [Full Text] [Related]
9. Genetics of Parkinson's disease. Lynch T; Farrer M; Hutton M; Hardy J Science; 1997 Nov; 278(5341):1212-3. PubMed ID: 9411743 [No Abstract] [Full Text] [Related]
10. Whole-mount analysis reveals normal numbers of dopaminergic neurons following misexpression of alpha-Synuclein in Drosophila. Pesah Y; Burgess H; Middlebrooks B; Ronningen K; Prosser J; Tirunagaru V; Zysk J; Mardon G Genesis; 2005 Apr; 41(4):154-9. PubMed ID: 15789427 [TBL] [Abstract][Full Text] [Related]
11. Neurobiology. Of flies and mice. Dawson VL Science; 2000 Apr; 288(5466):631-2. PubMed ID: 10799001 [No Abstract] [Full Text] [Related]
12. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease. Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676 [TBL] [Abstract][Full Text] [Related]
13. Gene dosage and pathogenesis of Parkinson's disease. Eriksen JL; Przedborski S; Petrucelli L Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766 [TBL] [Abstract][Full Text] [Related]
15. alpha-Synuclein locus triplication causes Parkinson's disease. Singleton AB; Farrer M; Johnson J; Singleton A; Hague S; Kachergus J; Hulihan M; Peuralinna T; Dutra A; Nussbaum R; Lincoln S; Crawley A; Hanson M; Maraganore D; Adler C; Cookson MR; Muenter M; Baptista M; Miller D; Blancato J; Hardy J; Gwinn-Hardy K Science; 2003 Oct; 302(5646):841. PubMed ID: 14593171 [No Abstract] [Full Text] [Related]
16. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678 [TBL] [Abstract][Full Text] [Related]
17. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208 [TBL] [Abstract][Full Text] [Related]
18. Nosology of Parkinson's disease: looking for the way out of a quagmire. Forman MS; Lee VM; Trojanowski JQ Neuron; 2005 Aug; 47(4):479-82. PubMed ID: 16102530 [TBL] [Abstract][Full Text] [Related]
19. Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease. Volles MJ; Lansbury PT Biochemistry; 2003 Jul; 42(26):7871-8. PubMed ID: 12834338 [TBL] [Abstract][Full Text] [Related]
20. Dopamine and Parkinson's disease: is the killer in the house? Chesselet MF Mol Psychiatry; 2003 Apr; 8(4):369-70. PubMed ID: 12740592 [No Abstract] [Full Text] [Related] [Next] [New Search]